2 results
Approved WMOCompleted
Evaluate the effect of tedalinab on ECG parameters, CNS Function and Pain Perception in Healthy Subjects.
Approved WMORecruiting
The primary objective of this study is to compare PFS with LY2875358 plus erlotinib therapy with erlotinibmonotherapy as first-line treatment in metastatic NSCLC patients with activating EGFR mutations who havedisease control after an 8-week lead-in…